Filters: author is Van der Geest [Clear All Filters]
- 2002
In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement,
J Control Release, vol. 84, no. 1-2, pp. 49-57. DOI
- 1999
Future delivery systems for apomorphine in patients with Parkinson's disease,
Adv Neurol, vol. 80, pp. 535-44.
- 1998
An integrated pharmacokinetic-pharmacodynamic approach to optimization of R-apomorphine delivery in Parkinson's disease,
Adv Drug Deliv Rev, vol. 33, no. 3, pp. 253-263. DOI
Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease,
Clin Neuropharmacol, vol. 21, no. 3, pp. 159-68.
Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease,
Clin Neuropharmacol, vol. 21, no. 3, pp. 152-8.
Validation and testing of a new iontophoretic continuous flow through transport cell,
J Control Release, vol. 51, no. 1, pp. 85-91. DOI
- 1997
Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease,
J Chromatogr B Biomed Sci Appl, vol. 702, no. 1-2, pp. 131-41.
Iontophoretic delivery of apomorphine. I: In vitro optimization and validation,
Pharm Res, vol. 14, no. 12, pp. 1798-803.
Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease,
Pharm Res, vol. 14, no. 12, pp. 1804-10.


